+++
title = 'Rossari Biotech Ltd - May 2025 Earnings Call Transcript Analysis'
date = 2025-05-05 20:00:24
readTime = true
tags = ["Rossari Biotech Ltd.", "ROSSARI", "Speciality Chemicals - Diversified", "Materials","Small Cap", "Earnings Call"]
showTags = true
toc = true
+++



## Earnings Call Transcript Analysis Report
## Financial Performance

### Key Financial Metrics (FY25 vs FY24)

#### Revenue from Operations

*   Rs. 2,080 crore, up 13.6% YoY. (Crossed Rs. 2,000 crore milestone).
    *   "For the full year FY25, we crossed the Rs. 2,000 crore milestone with revenue from operations reaching Rs. 2,080 crore, up 13.6% YoY."

#### EBITDA

*   Rs. 265.1 crore, up 6.1% YoY.

#### EBITDA Margin (Consolidated)

*   12.7% (down from 13.6% in FY24).
    *   "EBITDA increased by 6.1% to Rs. 265.1 crore with an EBITDA margin of 12.7% compared to 13.6% in FY24."

#### Core Business Adjusted EBITDA Margin (FY25)

*   Approximately 15%.
    *   "...our core business continues to deliver healthy profitability with an adjusted EBITDA range of approximately 15% for FY25."



{{< rawhtml >}}

<div class="button-container">    
    <a href="https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Transcript
    </a>
</div>
    
{{< /rawhtml >}}
